Evidence map›Paper›PMID 32521658›Full record

ArticleHigh-throughput2020

Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against

Omar Rossi, Eleonora Molesti, Allan Saul, Carlo Giannelli, Francesca Micoli, Francesca Necchi

Open access · goldAbstract read
In one paragraph

Article in High-throughput, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
0.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Antibodies Elicited by theFrontiers in immunology · 2021
    Trial
  5. Multifunctional antibody responses from a primateScience translational medicine · 2026
    Article
  6. Article
  7. Development of a NovelVaccines · 2026
    Article
  8. Article
  9. Article
  10. A multifunctional anti-O-Antigen human monoclonal antibody protects againstProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Immunogenicity evaluation of altSonflex1-2-3Frontiers in immunology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Toward aInternational journal of molecular sciences · 2023
    Review
  18. Article
  19. Functional assays to evaluate antibody-mediated responses againstFrontiers in cellular and infection microbiology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Omar RossiGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.ORCID 0000-0002-0170-1285
Eleonora MolestiGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.
Allan SaulGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.
Carlo GiannelliGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.ORCID 0000-0002-6112-6841
Francesca MicoliGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.
Francesca NecchiGSK Vaccines Institute for Global Health s.r.l (GVGH), Siena 53100, Italy.
Toscana Life Sciences · IT

Funding

Bill and Melinda Gates Foundation OPP1133860This study was undertaken at the request of and sponsored by GlaxoSmithKline Biologicals SA. GSK Vaccines Institute for Global Health (Srl) (GVGH) is an affiliate of GlaxoSmithKline Biologicals SA.
6 · The paper itself

Abstract

Despite the huge decrease in deaths caused by

Indexed as

functional assayGeneralized Modules for Membrane Antigens (GMMA)humanluminescenceSerum Bactericidal Assay (SBA)Shigellavaccine

Identifiers

PMID32521658
PMCPMC7361673
OpenAlexW3032909997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.